Direkt zum Inhalt
Merck
  • Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations.

Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations.

Journal of molecular modeling (2012-10-23)
Caijuan Shi, Rilei Yu, Shengjuan Shao, Yanni Li
ZUSAMMENFASSUNG

Nicotinic acetylcholine receptors (nAChRs) are drug targets for neuronal disorders and diseases. Partial agonists for nAChRs are currently being developed as drugs for the treatment of neurological diseases for their relative safety originated from reduced excessive stimulation. In the current study, molecular docking, molecular dynamics simulations and binding energy calculations were performed to theoretically investigate the interactions between the partial agonists, 4-OH-DMXBA and tropisetron with α7-nAChR. The results suggest that the partial agonists 4-OH-DMXBA and tropisetron bind with α7-nAChR in a binding mode similar to that with AChBP. The non-conserved residues in the binding sites contribute to the orientation deviation of these partial agonists from their orientation in AChBP. Energy calculation and decomposition using MM-GB/SA suggests that the van der Waals term (ΔE(VDW)) is the main driving force for the binding of the partial agonists to α7-nAChR. The molecular dynamics simulations showed that the opening of the C-loop binding with the partial agonists is in-between the openings for the binding with the full agonist and in the apo state. This conformation difference for the C-loop sheds light on the partial agonism of nAChR.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
GTS-21, ≥97% (HPLC)